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 1. Bacterial strains and cultures: Strains used were: thiomarinol producer Pseudoalteromonas sp SANK73390[1]; 
mupirocin producer Pseudomonas fluorescens NCIMB 10586[2]  and mutant derivatives; E.coli DH5α[3] for cloning 
and genetic manipulation; E.coli S17-1[4] to mobilize plasmids to other species. SANK 73309 was grown at 23oC 
on marine broth and agar[1]. Other bacteria were grown on standard L-Broth or L-Agar with appropriate antibiotics 
at 30oC (NCIMB 10586) or 37oC (E. coli strains). 
2. Gene cloning and heterologous expression: The tmuB gene was amplified with primers TmuBF 
5'GCAGAATTCATGGATAGTTTGCAGTCATTTA and TmuBR 5'CTGTCTAGAGAATCGTTGCTAATGCC using 
genomic DNA from the WT SANK 73309. Genes were inserted into vector pGEM-TEasy (Promega) as A-tailed 
inserts and transformed into competent E.coli DH5α[5]. DNA was sequenced in the Genomics Lab at the University 
of Birmingham using Big Dye Terminator kit (PE-ABI). tmuB was inserted into the expression vector, pJH10[6], as 
an EcoRI/XbaI fragment.  
3. Protein over expression and purification:  tmuB was inserted into pET28a as an Ndel/XhoI fragment to give 
an N-terminal His-tag. Transformed E.coli BL21 (DE3) were grown to OD600=0.5 before addition of IPTG (to 0.5mM) 
and incubation at 25oC for 16hr. Cells in 20mM Tris buffer pH7.5, 500mM NaCl supplemented with EDTA-free 
protease inhibitor were lysed using a French Press. The tagged protein was purified by Ni-NTA affinity 
chromatography and then gel filtration using HiLoad 16/600 Superdex S75 column (GE Healthcare). Selected 
fractions were concentrated by 5.000 MWCO Amicon Ultra-15 Centrifugal Filter. 
4. Mutagenesis of tmuB: Internal primers for site-directed mutagenesis were designed to create tmuB point 
mutations in combination with the outer primers TmuBF and TmuBR (see above) in the first PCR run to create one 
short fragment containing the mutation. This fragment was used as forward or reverse primer with the outer primers 
in the second PCR run to amplify the whole gene. The mutation was confirmed by sequencing, cloned to the 
expression vectors and mobilized to P. fluorescens strains via conjugal mating using E.coli S17-1    
5. Media preparation: M9 Minimal medium with tetracycline (200 ml of 3% agar, 200 ml of M9 x2 salts, 400 µl of 
0.1 M CaCl2, 400 µl of 1 M thiamine-HCl, 400 µl of 1 M MgSO4, 400 µl of Tetracycline (100 mg/ml) and 2 ml of 40% 
glucose) was used as a selective medium to inhibit E.coli S17-I growth after mating with P. fluorescens strains. 
Second stage medium (SSM) was used to produce mupirocin from P. fluorescens strains: per liter, 25g Soya flour, 
2.5g Spray dried corn liquor, 5g (NH4)2 SO4, 0.5g MgSO4 7H2O, 1g Na2HPO4, 1.5g KH2PO4, 6.25g CaCO3 were 
mixed with 850 ml distilled water, dissolved by stirring and heating, the pH adjusted to 7.5 by NaOH addition, the 
volume made up to 1 litre and autoclaved. Prior to setting up cultures, 40% (w/v) sterile glucose was added.   
6. HPLC analysis: For sample preparation a single colony of P. fluorescens with a chosen plasmid was used to 
inoculate L-broth supplemented with tetracycline (100µg/ml) and ampicillin (150µg/ml) and incubated overnight at 
25oC with shaking at 200 rpm. Second stage medium (SSM) was inoculated with 5% of the overnight culture (1.25 
ml to 25 ml of SSM) and incubated at 22oC for 40-60 hours with shaking at 200 rpm. After bacteria were pelleted 
at 8000 xg for 7 minute the supernatant was adjusted to pH 4.5 with HCl before filtering through a 0.2 µm Acrodisc 
syringe filter. For HPLC analysis solvent A (HPLC grade water) and solvent B (HPLC grade acetonitrile) were 
supplemented with 0.01% formic acid and degassed. A Gilson® 321 pump pumped the solvents at a flow rate of 1 
ml/min. Unipoint LC software was used to contro the HPLC. 100 µl of the sample was injected into a C18 column 
(15cm x 4.6mm, 5µm) and analysed with 233 nm UV light. 
7. Bioassays:  For mupirocin, bioassay was carried out by spotting 10µl bacterial overnight culture on 20 ml L-
agar and incubated for 16 h at 30oC[6]. This was overlaid with 15 ml molten agar at 45oC seeded with overnight 
culture of Bacillus subtilis 1064 (40µl/ml) and 0.5 ml of Triphenyl tetrazolium chloride (TTC) (5% w/v). After 18h at 
37oC, clear zones of inhibition around the bacterial spots were measured. For thiomarinol bioassay, 15 ml L agar 
was poured into a Petri dish, left to solidify, overlaid with 10 ml of the detection layer and left to solidify. The 
detection layer was prepared by mixing 4.75ml of melted L agar 48oC, 4.75ml pre warmed 48oC LB broth, 100µl of 
TTC 5% and 400µl of the Bacillus subtilis 1064 overnight culture. The paper disc with thiomarinol was prepared by 
adding thiomarinol stock solution slowly and allowing it to dry before placing it on the overlaid layer. After 18h at 
37oC, the clear zone of inhibition around the paper disc was measured.             
8. Minimal inhibitory concentration:  Overnight cultures of Bacillus subtilis diluted 1:100 in LB were incubated at 
37oC with shaking to OD600nm = 0.5 before dilution to OD600nm = 0.10 (0.5 McFarland standard)[7], 108 CFU/ml 
approx. This was further diluted 1:100 to give the working dilution (106 CFU/ml). To each well of a Costar® 96 flat-
bottom well microplate 100 µl of bacterial suspension and 100 µl of antibiotic dilutions were added and plates 
incubated at 37oC with shaking 200 rpm for 18-20hrs. The OD600nm was read with a SPECTROstar Nano microplate 
reader and three combination wavelengths (600nm, 900nm, 977nm) used to standardize water content in the well. 
These data were analysed using MARS software. 
9. Mass spectrometry and NMR: 1L cultures were incubated for product purification as for HPLC analysis. 
Bacteria were pelleted by centrifugation at 22,000 ×g for 20 min. The supernatant was extracted with ethyl acetate 
(1:1) once, and this was repeated after the aqueous phase was acidified to pH 5.0. The two extracts were combined 
and ethyl acetate evaporated in vacuo. The residue was dissolved in 3.0 ml MeOH for LCMS analysis. Samples 
were diluted 10-fold with MeOH and analysed by LCMS using a Waters HPLC system (Waters 2545 Binary 
Gradient Module; SFO System Fluidics Organizer; 2998 diode array detector). Detection was achieved by UV 
between 200 and 400 nm, and by simultaneous electrospray (ES) mass spectrometry using a Waters Quattro 
Micro™ API spectrometer detecting between 150 and 600 m/z units. Chromatography (flow rate 1 mL·min-1) was 
achieved using a Phenomenex Kinetex column (5 μ, C18, 100 Å, 4.6 × 250 mm). Solvents were: A, HPLC grade 
H2O, 0.05% formic acid; B, HPLC grade CH3CN, 0.045% formic acid. Analytical gradients were as follows: 0 min, 
5% B; 22 min, 60% B; 24 min, 95% B; 26 min, 95% B; 27 min, 5% B; 30 min, 5% B. LCMS purification of target 
compounds was performed on a preparative Phenomenex Kinetex column (5 μ, C18, 100 Å, AXIA 21.2 × 250 mm). 
Collection of target peaks was triggered by masses. Both positive (PI) and negative (NI) mode were employed to 
characterize target compounds together with UV absorption pattern. Comparative yield of target compounds were 
measured by ELS peaks. 
10. In vitro enzyme activity assay: After optimisation of activity as described in the main text, the standard assay 
of hydroxylase activity was run at 23oC in 500 µl buffer (20mM Tris-HCl pH7.5 and 500mM NaCl) with 5µg of TmuB 
protein, 0.2mM FeSO4 (Co-factor), 0.5mM α-keto glutaric acid (Co-substrate) and 0.5mM pseudomonic acid A. The 
reaction was stopped by adding an equal volume 100% acetonitrile, left for 5 min at room temperature, centrifuged 
at 13000 xg for 5 min and the supernatant analysed by HPLC. To find the optimal reaction conditions and initial 
velocity, temperature, time and concentrations of TmuB protein substrate, co-factor and co-substrate were varied. 
11. Bioinformatic analysis: DNA and protein sequences of tmuB were obtained from NCBI (accession no. 
FN689524 & protein id: CBK62743). HHpred (http://toolkit.tuebingen.mpg.de/hhpred)[8] was used to identify 
resolved protein structure. The four structures with the highest identities were 4NAO[9] , 4NMI[10] , 4MHR[11] and 
2AX1[12] (25%, 19%, 17% and 15% identity) respectively. DSSP[13] was used to determine the secondary structure 
of the templates. PSIPRED[14] and Jpred3 (http://www.compbio.dundee.ac.uk/jpred)[15] were used to predict TmuB 
secondary structure. ClustalX[16] was used to set up the initial multiple alignment and Seaview[17] software was 
used to manually refine the alignment guided by known and predicted secondary structure. Modeller version 9.12[18] 
was used to generate a homology model of TmuB based on the crystal structure of the EasH (4NAO). The overall 
geometric and stereo-chemical qualities of the final modelled structure of TmuB were evaluated using multiple 
program and online server such as PROSESS (http://www.prosess.ca/), WATCHECK[19], and RAMPAGE[20]. To 
elucidate the conformation of catalytic reaction of TmuB on the substrates, AutoDock4 and AutoDockTools 1.5.6 
[21][22] were used to dock the substrates into the modelled TmuB active site and analyse the interaction between 
protein and ligands. Rigid docking was performed using genetic algorithm with default docking parameters. 
AutoGrid was used to define the docking searching area in active site and the grid size set to 54 X 52 X 52 points, 
grid spacing of 0.375 Å and grid center 71.5 X 30.09 X 34.89. Before running the AutoGrid and AutoDock, manually 
+2.0 charge was added to the Fe ion and the hydrogen atom was removed from the His121 residues. Finally, the 
program PyMOL (http://www.pymol.org) was used to modify the substrate (PA-A to PA-B) and to visualize the 
predicted structure of TmuB protein.  
12. Mutagenesis in Pseudoalteromonas sp. SANK 73390: To inactivate tmuB in Pseudoalteromonas sp. SANK 
73390, the I109N change was introduced by suicide mutagenesis using a mutant tmuB cloned into suicide vector 
pAKE604 as a SalI/XbaI insert as previously described[23]. This plasmid was put into E.coli S17-1 and mobilised to 
WT Pseudoalteromonas sp. SANK 73390 by mixing 1ml overnight cultures of donor and recipient cultures and 
filtering onto a 0.45µm nylon membrane which was placed on marine agar and incubated overnight at 23oC. 
Bacteria were resuspended in 1 ml marine broth, serially diluted, spread on marine agar supplemented with 100-
200µg ml-1 kanamycin and incubated at 23oC for 3-4 days. Transconjugants with the plasmid integrated by 
homologous recombination were purified by repeated streaking to single colonies at 23oC on selective marina agar 
and then grown in non-selective marine broth to allow growth of bacteria in which the suicide plasmid had excised 
from the chromosome. Serial dilutions were spread on marine agar with 5% (w/v) sucrose and SucR colonies tested 
for kanamycin sensitivity. KanS and SucR colonies were checked by PCR and DNA sequencing. 
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Figure 1S. The influence of PA-B on TmuB activity while catalysing PA-A. The Km increased 
with increasing inhibitor concentration (as shown above) while Vmax remained unchanged. 
With adding of 30µM, 60 µM and 120 µM of PA-B, the Km increased to 28.9 µM, 31 µM and 
37 µM respectively.     
Figure 2S. The homology model of TmuB (15th) and the crystal structures of the templates, A. AsqJ 
and B. FtmOx1 protein. Of critical importance is the potentially mobile α-helix2/β3 loop that is 
missing from the EasH structure and is present in AsqJ and FtmOx1 protein. C. EasH protein and 
D. TmuB model generated according to the structure of AsqJ and FtmOx1. See TmuB model 
generated according to the EasH protein in Figure 3SA.  
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Figure 3S.  Ribbon diagram of predicted TmuB structure showing the “jelly roll”.  The β-strands II and 
VII are short and disordered while the other strands are well determined. The Fe+2 cofactor is bound by 
H121 and D123 of β-strand II and H191 on β-strand VII. Co-substrate, αKG, binds Fe+2 via C1-
carboxylate and C2-keto groups while the C5-carboxylate forms hydrogen bonds and electrostatic 
interactions with Q118, T154 and R202 located on loops I/II and III/IV and βVII. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4S.  The 15th homology model of TmuB showing the PA-A docked into the active site in presence of 
αKG (Green stick) and Fe II (Orange sphere). A. The surface mode showing the fatty acid chain interacting 
with the residues on helix2/β3 loop. B. The residues interacting with PA-A (pink stick) and the residues close 
to the different substrate sectors in the active site. The target site C4 is 4.2 Å from the Fe II.   
B 
A 
α-helix2/β3 
βII/III loop 
  
 
 
 
Figure 5S. The Evolutionary Trace analysis of the TmuB model and the templates showing the 
residues predicted to be most important as red and those predicted to be least important as blue. 
A and B: Lateral and front view of the TmuB model respectively, C: EasH, D: AsqJ, E: FAHX and 
F: EctD. The residues in the loop (Dashed circle) are vary in these resolved proteins while the six 
residues in the active site are highly conserved.     
A B C 
D 
E F 
Highly conserved  Non-conserved   
  
 
 
 
 
 
Figure 6S. Crystal structure of Isoleucyl-tRNA synthetase complex with PA-A (1FFY), visualized 
using PyMol in cartoon mode (A) and surface mode (B). Colour code: PA-A (purple); C4 in red 
dashed circle; Asp 557 (red); and His64 (blue). 
Asp557 
His64 
C4 
B 
A 
Asp557 
His64 
 Table 1S: Characterization of the new metabolites produced by P. fluorescens strains in presence of TmuB expression 
 
 
 
 
 
 
 
 
 
 
 
P. fluorescens strains 
transformed with 
pJH10 
-TmuB 
HPLC 
RT/min 
+TmuB HPLC 
RT/min 
-TmuB 
MS 
+TmuB 
MS 
NMR 
WT 20.2 18.2 500 516 4-hydroxy PA-A 
ΔmacpE 19.35 19.35 516 516 PA-B and trace of PA-A changed to 4-hydroxy PA-A 
ΔmupO 19.35 19.35 516 516 PA-B and trace of PA-A changed to 4-hydroxy PA-A 
ΔmupU 19.35 19.35 516 516 PA-B and trace of PA-A changed to 4-hydroxy PA-A 
ΔmupV 19.35 19.35 516 516 PA-B and trace of PA-A changed to 4-hydroxy PA-A 
ΔmmpE/OR 22.5 20.22 484 500 4-hydroxy PA-C 
ΔmupW 22 22 503 503 Mupirocin W 
ΔmupC 22.4 22.4 496 496 Mupirocin C 
ΔmupF 22.35 19.6 498 514 4-hydroxy mupirocin F 
 Table 2S. What-check and PROSESS evaluation for the homology structure of TmuB comparing with the templates, 5daw and 4NAO. The score out of 
(0 to -3) range is unacceptable for all criteria except the last two rows.  
Criteria Mod 8 Mod 10 Mod 12 Mod 15 5DAW 4NAO 
Resolution read from PDB file -1.000Å -1.000Å -1.000Å -1.000Å 1.600Å 1.650Å 
1st generation packing quality -3.032 -2.932 -2.491 -2.764 -0.709 -0.921 
2nd generation packing quality -3.195 -3.035 -1.988 -2.939 -1.519 -0.589 
Ramachandran plot appearance -0.550 -0.775 -4.531 -0.556 -0.513 0.024 
chi-1/chi-2 rotamer normality -1.099 -1.240 -4.063 -3.361 -1.477 0.206 
Backbone conformation -1.320 -2.022 -3.253 2.944 0.260 0.742 
Inside/Outside distribution 1.159 1.179 1.122 1.208 1.032 1.058 
PROSESS total score 4.5 3.5 3.0 3.5 7.5 6.5 
 
 
 
 
 
 
 
  
